Cardioembolism as a Mechanism of Central Retinal Artery Occlusion

心源性栓塞作为视网膜中央动脉闭塞的机制

基本信息

  • 批准号:
    10773701
  • 负责人:
  • 金额:
    $ 5.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-01 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

ABSTRACT This is an application for an Administrative Supplement to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award recipients. The purpose is to provide the principal investigator, Dr. Brian Mac Grory, with the support necessary to maintain his research output during a period of paternity leave. Dr. Mac Grory is a vascular neurology investigator pursuing patient-oriented clinical research focused on the identification of novel populations with underexplored cerebrovascular disorders requiring personalized secondary prevention strategies. Based on compelling preliminary data and recent publications, the central hypothesis of this proposal is that central retinal artery occlusion (CRAO) – a form of ischemic stroke affecting the retina – may be an indicator of underlying cardiac disease and a sentinel of future, potentially lethal, cardioembolic stroke. CRAO is formally recognized as a form of ischemic stroke but there is an incomplete understanding of its mechanistic underpinnings, with most research to-date focused on its association with carotid artery stenosis. The parent K23 award proposes to generate key preliminary data linking CRAO with cardioembolic substrates and set the stage for a future, multi-center, observational study that will definitively test this hypothesis. Dr. Mac Grory will leverage a very large population-based dataset (the Medicare 5% Sample) as well as both retrospective and prospective institutional cohorts. Specific Aims 1A & 1B will determine the association of each of atrial fibrillation and left ventricular failure with the development of CRAO and comprise the focus of the current application for an Administrative Supplement. Specific Aims 2A & 2B will determine the association of cardiac, serum and ultrasonographic biomarkers of embolic risk with CRAO and their interplay with carotid artery stenosis. As part of this proposal, Dr. Mac Grory will undertake a linked, didactic training plan with the goal of developing as an independent investigator through acquisition of the following key skills: 1) Biostatistics in observational research including advanced causal inference methodology, 2) Data science applied to administrative claims databases, 3) Prospective, observational study design, and 4) Vascular biomarker interpretation. Advanced training in these areas will permit Dr. Mac Grory to realize his long-term career goal of becoming an independent clinical investigator who leverages interdisciplinary expertise to provide insights in to the management of understudied cerebrovascular disorders. In pursuit of this goal, Dr. Mac Grory has assembled a mentoring team with distinct though complementary skillsets in stroke medicine, comparative effectiveness research, causal inference methodology, cardiac electrophysiology, and neuro-ophthalmology. With the preliminary data and training obtained from the proposed research, Dr. Mac Grory will be uniquely equipped to execute future, larger-scale studies uncovering novel populations in whom evidence-based, potentially life-saving secondary prevention strategies may be deployed. The scientific goals and approach remain unchanged from the original proposal.
摘要 这是一份行政副刊的申请,以促进NIH研究的连续性和保留性 指导职业发展(K)奖获得者。其目的是为首席研究员Dr。 在必要的支持下,他在陪产假期间保持了他的研究成果。 Mac Grory博士是一名血管神经学研究员,致力于以患者为导向的临床研究,重点是 需要个体化的未充分探索的脑血管疾病新人群的识别 二级预防策略。基于令人信服的初步数据和最近的出版物,中央银行 这一建议的假设是视网膜中央动脉阻塞(CRAO)--一种形式的缺血性中风 视网膜-可能是潜在心脏病的指示器,也是未来可能致命的哨兵, 心源性中风。CRAO被正式确认为缺血性中风的一种形式,但有一种不完全的 对其机制基础的理解,迄今大多数研究集中在其与 颈动脉狭窄。父K23奖项建议生成关键的初步数据,将CRAO与 并为未来的多中心观察性研究奠定了基础 检验这一假设。Mac Grory博士将利用一个非常大的基于人口的数据集(Medicare 5% 样本)以及回顾和预期的机构队列。具体目标1A和1B将 确定房颤和左心衰与CRAO发生的关系 并构成目前申请行政补编的重点。具体目标2A和2B 将确定心脏、血清和超声生物标记物的血栓风险与CRAO的关系 以及它们与颈动脉狭窄的相互作用。作为这项提案的一部分,Mac Grory博士将进行一项相关的 教学培训计划,目标是通过收购 以下关键技能:1)观察性研究中的生物统计学,包括高级因果推理 方法论,2)数据科学应用于行政索赔数据库,3)前瞻性,观察性研究 设计和4)血管生物标记物的解释。这些领域的高级培训将使Mac Grory博士能够 实现他长期的职业目标,成为一名独立的临床研究员,利用 跨学科的专业知识,为研究不足的脑血管疾病的管理提供洞察力。 为了追求这一目标,麦克·格罗里博士组建了一个指导团队,他们虽然互为补充,但却截然不同 中风医学、比较疗效研究、因果推理方法学、心脏 电生理学和神经眼科。初步数据和从 拟议的研究,Mac Grory博士将拥有独特的装备来执行未来更大规模的研究,揭示 可能采取循证的、可能挽救生命的二级预防策略的新人群 已部署。科学目标和方法与最初的提议保持不变。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Atrial fibrillation as a novel risk factor for retinal stroke: A protocol for a population-based retrospective cohort study.
心房颤动是视网膜中风的新风险因素:基于人群的回顾性队列研究方案。
  • DOI:
    10.1371/journal.pone.0296251
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Brian Mac Grory其他文献

Brian Mac Grory的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Brian Mac Grory', 18)}}的其他基金

Cardioembolism as a Mechanism of Central Retinal Artery Occlusion
心源性栓塞作为视网膜中央动脉闭塞的机制
  • 批准号:
    10525030
  • 财政年份:
    2022
  • 资助金额:
    $ 5.32万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.32万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 5.32万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.32万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.32万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.32万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.32万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.32万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 5.32万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 5.32万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 5.32万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了